Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

22
Number of overlapping holdings
21.0%
% of BMED's 115 holdings also in BBP
36.1%
% of BBP's 65 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in BMED |
Weight in BBP |
Overlap | |
---|---|---|---|---|
GILEAD SCIENCES INC | 3.7% | 2.1% | 2.1% | |
NEUROCRINE BIOSCIENCES INC | 1.5% | 1.5% | 1.5% | |
SAREPTA THERAPEUTICS INC | 1.4% | 1.4% | 1.4% | |
BEIGENE LTD. SPONSORED ADR | 1.4% | 2.3% | 1.4% | |
AMGEN INC | 1.3% | 2.0% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to BBP
BOSTON SCIENTIFIC CORP | 4.9% | |
INTUITIVE SURGICAL INC | 4.9% | |
ROCHE HOLDING AG-BR | 3.4% | |
ARGENX SE ADR | 3.3% | |
ABBVIE INC | 3.1% | |
LONZA GROUP AG-REG | 2.7% | |
ABBOTT LABORATORIES | 2.7% | |
MEDTRONIC PLC | 2.3% | |
UCB SA | 2.2% | |
BRISTOL-MYERS SQUIBB CO | 2.2% |
BMED Underweight Relative to BBP
INTRA-CELLULAR THERAPIES INC | -2.6% | |
ZAI LAB LTD. UNSPONSORED ADR | -2.2% | |
SAGE THERAPEUTICS INC | -2.2% | |
SPRINGWORKS THERAPEUTICS, INC. | -2.1% | |
TG THERAPEUTICS INC | -2.1% | |
DYNAVAX TECHNOLOGIES CORP | -1.8% | |
MADRIGAL PHARMACEUTICALS, INC. | -1.8% | |
BIOMARIN PHARMACEUTICAL INC | -1.8% | |
AXSOME THERAPEUTICS, INC. | -1.8% | |
HARMONY BIOSCIENCES HOLDINGS, INC. | -1.7% |